WINTON GROUP Ltd Has $1.18 Million Stock Position in Pediatrix Medical Group, Inc. (NYSE:MD)

WINTON GROUP Ltd cut its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 17.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 89,981 shares of the company's stock after selling 18,705 shares during the quarter. WINTON GROUP Ltd owned approximately 0.10% of Pediatrix Medical Group worth $1,181,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Quest Partners LLC boosted its holdings in shares of Pediatrix Medical Group by 25.6% in the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company's stock worth $35,000 after acquiring an additional 622 shares in the last quarter. Parkside Financial Bank & Trust raised its position in Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after purchasing an additional 1,040 shares during the last quarter. Quarry LP boosted its stake in Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company's stock worth $55,000 after purchasing an additional 1,662 shares in the last quarter. AlphaQuest LLC grew its holdings in shares of Pediatrix Medical Group by 65.9% during the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after purchasing an additional 2,012 shares during the last quarter. Finally, Smartleaf Asset Management LLC increased its stake in shares of Pediatrix Medical Group by 750.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock valued at $91,000 after buying an additional 6,090 shares in the last quarter. 97.71% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have commented on MD. Truist Financial increased their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a "hold" rating in a research report on Friday, February 21st. Macquarie initiated coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They issued an "outperform" rating and a $18.00 price objective for the company. StockNews.com raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Finally, UBS Group raised their target price on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a research note on Friday, February 21st. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $17.08.

Pediatrix Medical Group Trading Up 1.2 %

Shares of NYSE MD traded up $0.18 during midday trading on Wednesday, reaching $14.69. 92,557 shares of the stock were exchanged, compared to its average volume of 628,555. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $17.67. The business has a 50-day simple moving average of $14.42 and a two-hundred day simple moving average of $13.74. The company has a market capitalization of $1.26 billion, a price-to-earnings ratio of -12.24, a P/E/G ratio of 1.74 and a beta of 1.49.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The company had revenue of $502.36 million for the quarter, compared to analyst estimates of $486.22 million. As a group, equities research analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.